DMK PHARMACEUTICALS Corp reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
DMK PHARMACEUTICALS Corp has filed 1,210 SEC EDGAR filings since 13 Feb 1996

SEC filing history

Showing 76-100 of 775 matching filings.

Per page
25
Current page
4
DEFM14A File 001-36242

DEFINITIVE PROXY STATEMENT

Filing date
13 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36242

ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS

Filing date
13 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PREM14A File 001-36242

PRELIMINARY PROXY STATEMENTS RELATING TO MERGER OR ACQUISITION

Filing date
31 Mar 2023
Reporting date
24 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36242

CURRENT REPORT

Filing date
17 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
17 Mar 2023
Reporting date
16 Mar 2023
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
16 Mar 2023
Reporting date
16 Mar 2023
Next action
Verify source filing
10-K File 001-36242

ANNUAL REPORT

Filing date
16 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
424B5 File 333-267365

PROSPECTUS SUPPLEMENT

Filing date
14 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36242

ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS

Filing date
27 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
27 Feb 2023
Reporting date
24 Feb 2023
Next action
Verify source filing
4

BIRNDORF - CHANGES IN BENEFICIAL OWNERSHIP

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36242

QUARTERLY REPORT

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
04 Oct 2022
Reporting date
01 Oct 2022
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
04 Oct 2022
Reporting date
03 Oct 2022
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
23 Sep 2022
Reporting date
23 Sep 2022
Next action
Verify source filing
424B5 File 333-267365

COMMON STOCK AND WARRANTS

Filing date
23 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
21 Sep 2022
Reporting date
21 Sep 2022
Next action
Verify source filing
10-K/A File 001-36242

AMENDMENT NO. 2 TO FORM 10-K

Filing date
20 Sep 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-267365

EFFECT filing

Filing date
19 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
14 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .